Health
Diabetes vaccine gives promising results in a genetic subgroup – EurekAlert
A clinical study led by Linköping University, Sweden, and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type…
IMAGE: Johnny Ludvigsson, senior professor at Linköping University.
view more
Credit: Anna Nilsen/Linköping University
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body’s own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
…
-
General23 hours agoToni Lamond, known for her roles in Annie Get Your Gun and My Fair Lady, dies aged 93
-
Noosa News7 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified
-
General13 hours agoSex work influencers call out lack of transparency as young girls targeted by viral social media content
-
Business13 hours agoWhere to invest $10,000 in ASX ETFs this December